Sideritis scardica Extracts Demonstrate Neuroprotective Activity against Aβ25–35 Toxicity
Plants · 20.04.2023 · 12 (8) · 1716
DOI: 10.3390/plants12081716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plants, online erschienen am 20.04.2023. Verfasst von Antonis Ververis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurogenetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cyprus Institute of Neurology & Genetics.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most prevalent neurodegenerative condition, primarily affecting seniors. Despite the significant time and money spent over the past few decades, no therapy has been developed yet. In recent years, the research has focused on ameliorating the cytotoxic amyloid beta (Aβ) peptide aggregates and the increased elevated oxidative stress, two interconnected main AD hallmarks. Medicinal plants constitute a large pool for identifying bioactive compounds or mixtures with a therapeutic effect. Sideritis scardica (SS) has been previously characterized as neuroprotective toward AD. We investigated this ability of SS by generating eight distinct solvent fractions, which were chemically characterized and assessed for their antioxidant and neuroprotective potential. The majority of the fractions were rich in phenolics and flavonoids, and all except one showed significant antioxidant activity. Additionally, four SS extracts partly rescued the viability in Aβ25–35-treated SH-SY5Y human neuroblastoma cells, with the initial aqueous extract being the most potent and demonstrating similar activity in retinoic-acid-differentiated cells as well. These extracts were rich in neuroprotective substances, such as apigenin, myricetin-3-galactoside, and ellagic acid. Our findings indicate that specific SS mixtures can benefit the pharmaceutical industry to develop herbal drugs and functional food products that may alleviate AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurogenetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
- Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
- Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, Nicosia 2417, Cyprus.
ORCID-Profile: Antonis Ververis, Sotiris Kyriakou, Mihalis I Panayiotidis, Michael Plioukas, Kyproula Christodoulou
Förderung
- Cyprus Institute of Neurology & Genetics
Zitieren
APA
Ververis, A., Ioannou, K., Kyriakou, S., Violaki, N., Panayiotidis, M. I., Plioukas, M., & Christodoulou, K. (2023). Sideritis scardica Extracts Demonstrate Neuroprotective Activity against Aβ25–35 Toxicity. Plants, 12(8), 1716. https://doi.org/10.3390/plants12081716
Vancouver
Ververis A, Ioannou K, Kyriakou S, Violaki N, Panayiotidis MI, Plioukas M, et al. Sideritis scardica Extracts Demonstrate Neuroprotective Activity against Aβ25–35 Toxicity. Plants. 2023;12(8):1716. doi:10.3390/plants12081716
BibTeX
@article{Ververis2023,
author = {Ververis, Antonis and Ioannou, Kristia and Kyriakou, Sotiris and Violaki, Niki and Panayiotidis, Mihalis I and Plioukas, Michael and Christodoulou, Kyproula},
title = {Sideritis scardica Extracts Demonstrate Neuroprotective Activity against Aβ25–35 Toxicity},
journal = {Plants},
year = {2023},
volume = {12},
number = {8},
pages = {1716},
doi = {10.3390/plants12081716}
}
EUVIMED